141 related articles for article (PubMed ID: 14584661)
1. Adjuvant chemotherapy following surgery in the management of uterine sarcomas.
Szánthó A; Bálega J; Szabó I; Demeter A; Sipos N; Csapó Z; Papp Z
Eur J Gynaecol Oncol; 2003; 24(5):421-4. PubMed ID: 14584661
[TBL] [Abstract][Full Text] [Related]
2. Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial.
Hempling RE; Piver MS; Baker TR
Am J Clin Oncol; 1995 Aug; 18(4):282-6. PubMed ID: 7625366
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up.
Odunsi K; Moneke V; Tammela J; Ghamande S; Seago P; Driscoll D; Marchetti D; Baker T; Lele S
Int J Gynecol Cancer; 2004; 14(4):659-64. PubMed ID: 15304162
[TBL] [Abstract][Full Text] [Related]
4. Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas.
Piver MS; Lele SB; Marchetti DL; Emrich LJ
J Surg Oncol; 1988 Aug; 38(4):233-9. PubMed ID: 3045423
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant vincristine, dactinomycin, and cyclophosphamide therapy in stage I uterine sarcomas. A pilot study.
van Nagell JR; Hanson MB; Donaldson ES; Gallion HH
Cancer; 1986 Apr; 57(8):1451-4. PubMed ID: 3948125
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
Gadducci A; Romanini A
Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
[TBL] [Abstract][Full Text] [Related]
8. [Uterine sarcoma. Retrospective analysis of a series of 22 cases].
Mage P; Chauvergne J; Bui NB; Avril A; Trojani M; Richaud P; Germain T; Maree D
J Gynecol Obstet Biol Reprod (Paris); 1984; 13(7):802-7. PubMed ID: 6549321
[TBL] [Abstract][Full Text] [Related]
9. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of chemotherapeutical protocols in the treatment of uterine sarcomas (Vincristine, actinomycin D, Cyclophosphamide VAC versus ifosfamide).
Simşek T; Uner M; Trak B; Erman O; Zorlu GC
Eur J Gynaecol Oncol; 1998; 19(4):405-7. PubMed ID: 9744738
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Bramwell V; Rouesse J; Steward W; Santoro A; Schraffordt-Koops H; Buesa J; Ruka W; Priario J; Wagener T; Burgers M
J Clin Oncol; 1994 Jun; 12(6):1137-49. PubMed ID: 8201375
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas.
Sorbe B
Gynecol Oncol; 1985 Mar; 20(3):281-9. PubMed ID: 3838290
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
[TBL] [Abstract][Full Text] [Related]
14. Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.
Edmonson JH; Fleming TR; Ivins JC; Burgert EO; Soule EH; O'Connell MJ; Sim FH; Ahmann DL
J Clin Oncol; 1984 Dec; 2(12):1390-6. PubMed ID: 6512582
[TBL] [Abstract][Full Text] [Related]
15. The retrospective analysis of patients with uterine sarcomas: A single-center experience.
Terek MC; Akman L; Hursitoglu BS; Sanli UA; Ozsaran Z; Tekindal MA; Dikmen Y; Zekioglu O; Ozsaran AA
J Cancer Res Ther; 2016; 12(1):309-13. PubMed ID: 27072256
[TBL] [Abstract][Full Text] [Related]
16. [Pilot study of an alternative CYVADIC + CBDCA protocol for adult soft tissue sarcoma as adjuvant chemotherapy].
Matsumoto S; Kawaguchi N; Manabe J; Matsushita Y; Tanizawa T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1571-4. PubMed ID: 12355942
[TBL] [Abstract][Full Text] [Related]
17. Stages I to II WHO 2003-defined low-grade endometrial stromal sarcoma: how much primary therapy is needed and how little is enough?
Feng W; Hua K; Malpica A; Zhou X; Baak JP
Int J Gynecol Cancer; 2013 Mar; 23(3):488-93. PubMed ID: 23435438
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic results in uterine sarcoma (1955-1985)].
Köhler U; Spröwitz M; Richter R; Bilek K; Forberg J
Zentralbl Gynakol; 1988; 110(20):283-9. PubMed ID: 3239303
[TBL] [Abstract][Full Text] [Related]
19. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group.
Meurer M; Floquet A; Ray-Coquard I; Bertucci F; Auriche M; Cordoba A; Piperno-Neumann S; Salas S; Delannes M; Chevalier T; Italiano A; Blay JY; Mancini J; Pautier P; Duffaud F
Int J Gynecol Cancer; 2019 May; 29(4):691-698. PubMed ID: 30772825
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, vincristine, adriamycin, and dimethyl-triazeno imidazole carboxamide (CYVADIC) for sarcomas of the female genital tract.
Piver MS; DeEulis TG; Lele SB; Barlow JJ
Gynecol Oncol; 1982 Dec; 14(3):319-23. PubMed ID: 6897542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
